Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
What this study shows
mTORC2 (rictor) controls the actin cytoskeleton and is rapamycin-insensitive, defining a second mTOR complex in mammals.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Mammalian cells) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Mammalian cells |
| Journal | Nature cell biology |
| Year | 2004 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/ncb1183 · PMID 15467718 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Biochemical/genetic (mTORC2/rictor) |
| Target | mTORC2 / actin cytoskeleton |
| Model | Mammalian cells |
| Effect | mTORC2 (mTOR-mLST8-rictor) controls the actin cytoskeleton and is rapamycin-insensitive |
In the Atlas
Related topics
Links in the pathway map
- Supports mTORC2 activates Actin cytoskeleton
- Supports Rictor required-for mTORC2
More studies on this topic
- mTORC2 controls actin polymerization required for consolidation of long-term memory (2013)
- Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control (2002)
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton (2004)
Was this page useful?
Thank you. Your answer was counted anonymously.